Juan J. Badimón

34.7k total citations · 8 hit papers
305 papers, 21.3k citations indexed

About

Juan J. Badimón is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juan J. Badimón has authored 305 papers receiving a total of 21.3k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Cardiology and Cardiovascular Medicine, 138 papers in Surgery and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juan J. Badimón's work include Antiplatelet Therapy and Cardiovascular Diseases (67 papers), Coronary Interventions and Diagnostics (64 papers) and Lipoproteins and Cardiovascular Health (44 papers). Juan J. Badimón is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (67 papers), Coronary Interventions and Diagnostics (64 papers) and Lipoproteins and Cardiovascular Health (44 papers). Juan J. Badimón collaborates with scholars based in United States, Spain and United Kingdom. Juan J. Badimón's co-authors include Valentı́n Fuster, Lina Badimón, James H. Chesebro, John T. Fallon, Zahi A. Fayad, Roberto Corti, Franklin H. Epstein, Carlos G. Santos‐Gallego, Gérard Helft and Stephen G. Worthley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Juan J. Badimón

296 papers receiving 20.7k citations

Hit Papers

The Pathogenesis of Coron... 1990 2026 2002 2014 1992 1999 1990 1990 1995 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
    1992 2.2k citations Valentı́n Fuster, Juan J. Badimón et al. profile →
  2. Blood-borne tissue factor: Another view of thrombosis
    1999 772 citations Ursula Rauch, John T. Fallon et al. profile →
  3. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
    1990 623 citations Juan J. Badimón, Valentı́n Fuster et al. profile →
  4. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
    1990 603 citations Valentı́n Fuster, Juan J. Badimón et al. Journal of the American College of Cardiology profile →
  5. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
    1995 575 citations Juan J. Badimón, John T. Fallon et al. profile →
  6. Atherothrombosis and High-Risk Plaque
    2005 543 citations Valentı́n Fuster, Pedro Moreno et al. Journal of the American College of Cardiology profile →
  7. Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
    2019 474 citations Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez et al. Journal of the American College of Cardiology profile →
  8. Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
    2021 189 citations Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan J. Badimón United States 70 8.7k 8.3k 4.6k 3.8k 3.4k 305 21.3k
Lina Badimón Spain 86 13.8k 1.6× 11.7k 1.4× 3.8k 0.8× 3.5k 0.9× 7.8k 2.3× 700 35.1k
Meinrad Gawaz Germany 82 11.6k 1.3× 5.8k 0.7× 2.8k 0.6× 1.4k 0.4× 5.5k 1.6× 607 26.7k
Erling Falk Denmark 56 7.1k 0.8× 7.2k 0.9× 3.7k 0.8× 4.5k 1.2× 2.7k 0.8× 179 17.3k
Stefan Blankenberg Germany 77 10.7k 1.2× 5.1k 0.6× 2.3k 0.5× 2.6k 0.7× 3.7k 1.1× 671 22.0k
Attilio Maseri Italy 76 15.2k 1.7× 7.2k 0.9× 2.5k 0.5× 6.3k 1.6× 3.7k 1.1× 314 28.1k
Yangsoo Jang South Korea 69 9.8k 1.1× 10.9k 1.3× 3.7k 0.8× 4.6k 1.2× 2.9k 0.9× 953 22.4k
Albert Schömig Germany 104 25.9k 3.0× 20.0k 2.4× 5.1k 1.1× 9.3k 2.4× 4.0k 1.2× 605 39.6k
Prediman K. Shah United States 72 5.9k 0.7× 6.7k 0.8× 2.0k 0.4× 2.5k 0.7× 3.1k 0.9× 329 18.6k
Emile R. Mohler United States 58 6.7k 0.8× 5.5k 0.7× 4.1k 0.9× 1.8k 0.5× 2.3k 0.7× 237 16.1k
Raffaele De Caterina Italy 79 11.7k 1.3× 5.5k 0.7× 1.5k 0.3× 1.9k 0.5× 3.3k 1.0× 659 24.4k

Countries citing papers authored by Juan J. Badimón

Since Specialization
Citations

This map shows the geographic impact of Juan J. Badimón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan J. Badimón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan J. Badimón more than expected).

Fields of papers citing papers by Juan J. Badimón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan J. Badimón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan J. Badimón. The network helps show where Juan J. Badimón may publish in the future.

Co-authorship network of co-authors of Juan J. Badimón

This figure shows the co-authorship network connecting the top 25 collaborators of Juan J. Badimón. A scholar is included among the top collaborators of Juan J. Badimón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan J. Badimón. Juan J. Badimón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Requena-Ibáñez, Juan Antonio, M. Urooj Zafar, Ginés Escolar, et al.. (2025). Rationale and Design of the SOTA-THROMBOSIS Trial (ATRU-VI): Antithrombotic Activities of Sotagliflozin Compared With Empagliflozin. Journal of Cardiovascular Pharmacology. 86(5). 458–462. 1 indexed citations
2.
Requena-Ibáñez, Juan Antonio, et al.. (2025). Sotagliflozin: Two Birds with One Stone?. Cardiovascular Drugs and Therapy. 40(2). 671–679. 2 indexed citations
3.
Filtz, Annalisa, Andrea Scotti, Juan J. Badimón, et al.. (2024). New approaches to triglyceride reduction: Is there any hope left?. SHILAP Revista de lepidopterología. 18. 100648–100648. 9 indexed citations
4.
Requena-Ibáñez, Juan Antonio, et al.. (2024). Inhibición dual del SGLT1 y SGLT2: algo más que su suma. Revista Española de Cardiología. 77(7). 510–514.
5.
Requena-Ibáñez, Juan Antonio, et al.. (2023). Uncovering the Role of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction. JACC Advances. 2(9). 100657–100657. 24 indexed citations
6.
Vargas-Delgado, Ariana P., et al.. (2023). Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors. International Journal of Molecular Sciences. 24(4). 4144–4144. 10 indexed citations
7.
Santos‐Gallego, Carlos G., Juan Antonio Requena-Ibáñez, Belén Picatoste, et al.. (2023). Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction. Circulation Cardiovascular Imaging. 16(4). e015298–e015298. 57 indexed citations
8.
Santos‐Gallego, Carlos G., Juan Antonio Requena-Ibáñez, Kiyotake Ishikawa, et al.. (2022). Abstract 15407: Benefits of the Sglt2 Inhibitor Empagliflozin on Epicardial Adipose Tissue in Non-Diabetic Hfref. Circulation. 146(Suppl_1). 1 indexed citations
9.
Santos‐Gallego, Carlos G., et al.. (2021). Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?. Clínica e Investigación en Arteriosclerosis (English Edition). 33(1). 33–40. 1 indexed citations
10.
11.
Chudnovskiy, Aleksey, Dong Kwon Yang, Dongtak Jeong, et al.. (2014). Alternatively Spliced Tissue Factor promotes plaque progression, inflammation and angiogenesis in experimental atherosclerosis. Circulation. 130. 1 indexed citations
12.
Giannarelli, Chiara, Matilde Alique, Dong Kwon Yang, et al.. (2014). Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor Signaling. Circulation. 130(15). 1274–1286. 42 indexed citations
13.
Badimón, Juan J. & Borja Ibáñez. (2010). Increasing High-Density Lipoprotein as a Therapeutic Target in Atherothrombotic Disease. Revista Española de Cardiología (English Edition). 63(3). 323–333. 13 indexed citations
14.
Zafar, M. Urooj, Borja Ibáñez, Brian G. Choi, et al.. (2009). A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel in a randomised phase I study. Thrombosis and Haemostasis. 103(1). 205–212. 25 indexed citations
15.
Ibáñez, Borja, S Prat, Walter S. Speidl, et al.. (2007). Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage. Circulation. 115(23). 2909–2916. 117 indexed citations
16.
Anand, Sunil X., Juan F. Viles-González, Juan J. Badimón, Erdal Çavuşoğlu, & Jonathan D. Marmur. (2003). Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thrombosis and Haemostasis. 90(9). 377–384. 128 indexed citations
17.
Sambola, Antonia, James Hathcock, Julio Osende, et al.. (2002). Increased circulating tissue factor and blood thrombogenicity in Type-2 diabetes. Journal of the American College of Cardiology. 39. 202–202. 4 indexed citations
18.
Osende, Julio, Juan J. Badimón, Valentı́n Fuster, et al.. (2001). Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. Journal of the American College of Cardiology. 38(5). 1307–1312. 119 indexed citations
19.
Helft, Gérard, Stephen G. Worthley, Valentı́n Fuster, et al.. (2001). Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. Journal of the American College of Cardiology. 37(4). 1149–1154. 79 indexed citations
20.
Freudenberger, Ronald S., Jeffrey D. Alexis, Alan Gass, Valentı́n Fuster, & Juan J. Badimón. (1999). Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. The Journal of Heart and Lung Transplantation. 18(12). 1228–1231. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lina Badimón Breakdown of academic impact, for papers by Meinrad Gawaz Breakdown of academic impact, for papers by Erling Falk Breakdown of academic impact, for papers by Stefan Blankenberg Breakdown of academic impact, for papers by Attilio Maseri Breakdown of academic impact, for papers by Yangsoo Jang Breakdown of academic impact, for papers by Albert Schömig Breakdown of academic impact, for papers by Prediman K. Shah Breakdown of academic impact, for papers by Emile R. Mohler Breakdown of academic impact, for papers by Raffaele De Caterina
Rankless by CCL
2026